Skip to main content
Journal cover image

Future directions in pharmacogenomics discovery in cardiovascular disease.

Publication ,  Journal Article
Friede, KA; Voora, D
Published in: Pharmacogenomics
April 2018

Duke Scholars

Published In

Pharmacogenomics

DOI

EISSN

1744-8042

Publication Date

April 2018

Volume

19

Issue

5

Start / End Page

375 / 377

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Pharmacogenetics
  • Humans
  • Genome-Wide Association Study
  • Forecasting
  • Drug Hypersensitivity
  • Dideoxynucleosides
  • Cardiovascular Diseases
  • Anti-HIV Agents
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friede, K. A., & Voora, D. (2018). Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics, 19(5), 375–377. https://doi.org/10.2217/pgs-2018-0002
Friede, Kevin A., and Deepak Voora. “Future directions in pharmacogenomics discovery in cardiovascular disease.Pharmacogenomics 19, no. 5 (April 2018): 375–77. https://doi.org/10.2217/pgs-2018-0002.
Friede KA, Voora D. Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics. 2018 Apr;19(5):375–7.
Friede, Kevin A., and Deepak Voora. “Future directions in pharmacogenomics discovery in cardiovascular disease.Pharmacogenomics, vol. 19, no. 5, Apr. 2018, pp. 375–77. Pubmed, doi:10.2217/pgs-2018-0002.
Friede KA, Voora D. Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics. 2018 Apr;19(5):375–377.
Journal cover image

Published In

Pharmacogenomics

DOI

EISSN

1744-8042

Publication Date

April 2018

Volume

19

Issue

5

Start / End Page

375 / 377

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Pharmacogenetics
  • Humans
  • Genome-Wide Association Study
  • Forecasting
  • Drug Hypersensitivity
  • Dideoxynucleosides
  • Cardiovascular Diseases
  • Anti-HIV Agents
  • 3214 Pharmacology and pharmaceutical sciences